These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 24321164

  • 1. Evaluating the effects of amantadin, modafinil and acetyl-L-carnitine on fatigue in multiple sclerosis--result of a pilot randomized, blind study.
    Ledinek AH, Sajko MC, Rot U.
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S86-9. PubMed ID: 24321164
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.
    Tomassini V, Pozzilli C, Onesti E, Pasqualetti P, Marinelli F, Pisani A, Fieschi C.
    J Neurol Sci; 2004 Mar 15; 218(1-2):103-8. PubMed ID: 14759641
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study.
    Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN.
    J Neurol Neurosurg Psychiatry; 2002 Feb 15; 72(2):179-83. PubMed ID: 11796766
    [Abstract] [Full Text] [Related]

  • 4. Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study.
    Zifko UA, Rupp M, Schwarz S, Zipko HT, Maida EM.
    J Neurol; 2002 Aug 15; 249(8):983-7. PubMed ID: 12195441
    [Abstract] [Full Text] [Related]

  • 5. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.
    Stankoff B, Waubant E, Confavreux C, Edan G, Debouverie M, Rumbach L, Moreau T, Pelletier J, Lubetzki C, Clanet M, French Modafinil Study Group.
    Neurology; 2005 Apr 12; 64(7):1139-43. PubMed ID: 15824337
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.
    Nourbakhsh B, Revirajan N, Morris B, Cordano C, Creasman J, Manguinao M, Krysko K, Rutatangwa A, Auvray C, Aljarallah S, Jin C, Mowry E, McCulloch C, Waubant E.
    Lancet Neurol; 2021 Jan 12; 20(1):38-48. PubMed ID: 33242419
    [Abstract] [Full Text] [Related]

  • 7. HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis.
    Möller F, Poettgen J, Broemel F, Neuhaus A, Daumer M, Heesen C.
    Mult Scler; 2011 Aug 12; 17(8):1002-9. PubMed ID: 21561959
    [Abstract] [Full Text] [Related]

  • 8. Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.
    Nourbakhsh B, Revirajan N, Waubant E.
    Contemp Clin Trials; 2018 Jan 12; 64():67-76. PubMed ID: 29113955
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological treatments for fatigue in patients with multiple sclerosis: A systematic review and meta-analysis.
    Yang TT, Wang L, Deng XY, Yu G.
    J Neurol Sci; 2017 Sep 15; 380():256-261. PubMed ID: 28870581
    [Abstract] [Full Text] [Related]

  • 10. Amantadine and the place of acupuncture in the treatment of fatigue in patients with multiple sclerosis: an observational study.
    Foroughipour M, Bahrami Taghanaki HR, Saeidi M, Khazaei M, Sasannezhad P, Shoeibi A.
    Acupunct Med; 2013 Mar 15; 31(1):27-30. PubMed ID: 23151355
    [Abstract] [Full Text] [Related]

  • 11. Carnitine for fatigue in multiple sclerosis.
    Tejani AM, Wasdell M, Spiwak R, Rowell G, Nathwani S.
    Cochrane Database Syst Rev; 2010 Feb 17; (2):CD007280. PubMed ID: 20166093
    [Abstract] [Full Text] [Related]

  • 12. Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis?
    Ashtari F, Fatehi F, Shaygannejad V, Chitsaz A.
    Neurol Neurochir Pol; 2009 Feb 17; 43(5):428-32. PubMed ID: 20054744
    [Abstract] [Full Text] [Related]

  • 13. Carnitine for fatigue in multiple sclerosis.
    Tejani AM, Wasdell M, Spiwak R, Rowell G, Nathwani S.
    Cochrane Database Syst Rev; 2012 May 16; 2012(5):CD007280. PubMed ID: 22592719
    [Abstract] [Full Text] [Related]

  • 14. Modafinil for multiple sclerosis fatigue: does it work?
    Littleton ET, Hobart JC, Palace J.
    Clin Neurol Neurosurg; 2010 Jan 16; 112(1):29-31. PubMed ID: 19837509
    [Abstract] [Full Text] [Related]

  • 15. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.
    Yadav V, Marracci G, Kim E, Spain R, Cameron M, Overs S, Riddehough A, Li DK, McDougall J, Lovera J, Murchison C, Bourdette D.
    Mult Scler Relat Disord; 2016 Sep 16; 9():80-90. PubMed ID: 27645350
    [Abstract] [Full Text] [Related]

  • 16. Modafinil for the treatment of multiple sclerosis-related fatigue.
    Brown JN, Howard CA, Kemp DW.
    Ann Pharmacother; 2010 Jun 16; 44(6):1098-103. PubMed ID: 20442351
    [Abstract] [Full Text] [Related]

  • 17. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo.
    Krupp LB, Coyle PK, Doscher C, Miller A, Cross AH, Jandorf L, Halper J, Johnson B, Morgante L, Grimson R.
    Neurology; 1995 Nov 16; 45(11):1956-61. PubMed ID: 7501140
    [Abstract] [Full Text] [Related]

  • 18. Meta-analysis of the efficacy of modafinil versus placebo in the treatment of multiple sclerosis fatigue.
    Shangyan H, Kuiqing L, Yumin X, Jie C, Weixiong L.
    Mult Scler Relat Disord; 2018 Jan 16; 19():85-89. PubMed ID: 29175676
    [Abstract] [Full Text] [Related]

  • 19. Using modafinil to treat fatigue in Parkinson disease: a double-blind, placebo-controlled pilot study.
    Lou JS, Dimitrova DM, Park BS, Johnson SC, Eaton R, Arnold G, Nutt JG.
    Clin Neuropharmacol; 2009 Jan 16; 32(6):305-10. PubMed ID: 19620846
    [Abstract] [Full Text] [Related]

  • 20. Amantadine influences cognitive processing in patients with multiple sclerosis.
    Sailer M, Heinze HJ, Schoenfeld MA, Hauser U, Smid HG.
    Pharmacopsychiatry; 2000 Jan 16; 33(1):28-37. PubMed ID: 10721881
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.